scholarly article | Q13442814 |
P50 | author | Eleanor J. Barnes | Q32637041 |
Michael Pavlides | Q43405332 | ||
Kenneth Fleming | Q46098555 | ||
Elizabeth M Tunnicliffe | Q51100253 | ||
P2093 | author name string | Stefan Neubauer | |
Matthew D Robson | |||
Rajarshi Banerjee | |||
Jane Collier | |||
Lai Mun Wang | |||
Catherine Kelly | |||
Jeremy F Cobbold | |||
P2860 | cites work | Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 |
The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study. | Q30364476 | ||
Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. | Q30366572 | ||
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease | Q30389327 | ||
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study | Q30418856 | ||
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease | Q30445138 | ||
MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score | Q33858748 | ||
Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold | Q34403474 | ||
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. | Q34544284 | ||
Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery | Q37615609 | ||
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragments | Q38168939 | ||
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies | Q38207382 | ||
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. | Q41042091 | ||
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States | Q41626076 | ||
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up | Q42201783 | ||
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease | Q44227516 | ||
No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial | Q44997998 | ||
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations | Q46078112 | ||
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. | Q46124754 | ||
Sampling variability of liver fibrosis in chronic hepatitis C. | Q48583601 | ||
A population-based study on the prevalence of NASH using scores validated against liver histology. | Q51330074 | ||
MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. | Q51431525 | ||
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study | Q51541188 | ||
A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1 ) in the liver. | Q53062749 | ||
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography | Q61567953 | ||
Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease | Q87164941 | ||
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | Q87406034 | ||
P433 | issue | 7 | |
P921 | main subject | liver disease | Q929737 |
metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
non-alcoholic fatty liver | Q66299798 | ||
P304 | page(s) | 1065-1073 | |
P577 | publication date | 2017-05-30 | |
P1433 | published in | Liver International | Q15765078 |
P1476 | title | Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity | |
P478 | volume | 37 |
Q99564871 | A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis |
Q91600205 | Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum |
Q90640984 | Dysregulated liver lipid metabolism and innate immunity associated with hepatic steatosis in neonatal BBdp rats and NOD mice |
Q61796245 | Evolving role of magnetic resonance techniques in primary sclerosing cholangitis |
Q64228361 | High performance of intravoxel incoherent motion diffusion MRI in detecting viral hepatitis-b induced liver fibrosis |
Q48101341 | Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis |
Q92419433 | Liver MR relaxometry at 3T - segmental normal T1 and T2* values in patients without focal or diffuse liver disease and in patients with increased liver fat and elevated liver stiffness |
Q100994722 | Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
Q89143797 | Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study |
Q92727108 | Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study |
Q57173225 | Noninvasive biomarkers in NAFLD and NASH - current progress and future promise |
Q57069715 | Obesity and nonalcoholic fatty liver disease: current perspectives |
Q48170451 | Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. |
Q38614820 | Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors |
Q91841927 | Radiomics based on artificial intelligence in liver diseases: where we are? |
Q57170235 | Recent research trends and updates on nonalcoholic fatty liver disease |
Q64061112 | Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver |
Q94475611 | Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet? |
Q46476704 | Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions |
Q47260332 | Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. |
Q58760217 | Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial |